Investing
618 Articles
ThinkstockDividend payments by S&P 500 companies reached an all-time high last year, totaling some $330.8 billion, according to FactSet. As…
The NYSE Arca Biotechnology Index fell nearly 9% between a peak on Jan. 22 and a low on Feb. 5.…
UPS reported first-quarter 2014 results before markets opened Thursday, and no surprise, winter weather was its theme of the day.…
Eli Lilly reported disappointing first-quarter 2014 results before markets opened Thursday, due in part to the impact of U.S. patent…
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, April 3, 2014.…
The chief strategist at Piper Jaffray released his report for March. It details how the second and third quarters typically…
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the…
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to…
Most Wall Street firms run model portfolios for their institutional and retail clients. Here are stocks that recently were added…
Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…
With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…
Ariad Pharmaceuticals could be joining the ranks of the next big biotech acquisitions. The company fits the bill of many…
ThinkstockPfizer Inc.’s (NYSE: PFE) patent protecting popular erectile dysfunction drug Viagra from generic competition may not expire until April 2020,…
Jon OggNow that we are mostly through earnings season and now that stocks have challenged all-time highs recently, investors and…
courtesy Deere & Co.UBS has a list of stocks that investors may want to consider selling. They could even be…
Our top personal finance-related articles today. Your wallet will thank you later.